Nicotinamide nucleotide synthesis in regenerating rat liver.
1. The concentrations and total content of the nicotinamide nucleotides were measured in the livers of rats at various times after partial hepatectomy and laparotomy (sham hepatectomy) and correlated with other events in the regeneration process. 2. The NAD content and concentration in rat liver were relatively unaffected by laparotomy, but fell to a minimum, 25 and 33% below control values respectively, 24h after partial hepatectomy. NADP content and concentration were affected similarly by both laparotomy and partial hepatectomy, falling rapidly and remaining depressed for up to 48h. 3. The effect of injecting various doses of nicotinamide on the liver DNA and NAD 18h after partial hepatectomy was studied and revealed an inverse correlation between NAD content and DNA content. 4. Injections of nicotinamide at various times after partial hepatectomy revealed that the ability to synthesize NAD from nicotinamide was impaired during the first 12h, rose to a peak at 26h and fell again by 48h after partial hepatectomy. 5. The total liver activity of NAD pyrophosphorylase (EC 2.7.7.1) remained at or slightly above the initial value for 12h after partial hepatectomy and then rose continuously until 48h after operation. The activity of NMN pyrophosphorylase (EC 2.4.2.12) showed a similar pattern of change after partial hepatectomy, but was at no time greater than 5% of the activity of NAD pyrophosphorylase. 6. The results are discussed with reference to the control of NAD synthesis in rapidly dividing tissue. It is suggested that the availability of cofactors and substrates for NAD synthesis is more important as a controlling factor than the maximum enzyme activities. It is concluded that the low concentrations of nicotinamide nucleotides in rapidly dividing tissues are the result of competition between NAD synthesis and nucleic acid synthesis for common precursor and cofactors.
D000818:Animals; D002467:Cell Nucleus; D004247:DNA / Q000032:analysis; D005260:Female; D006498:Hepatectomy; D007274:Injections, Intraperitoneal; D007813:Laparotomy; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008115:Liver Regeneration; D009243:NAD / Q000096:biosynthesis*; D009249:NADP / Q000096:biosynthesis*; D009536:Niacinamide / Q000494:pharmacology; D009696:Nucleic Acids / Q000096:biosynthesis; D009713:Nucleotidyltransferases / Q000032:analysis; D010430:Pentosyltransferases / Q000032:analysis; D051381:Rats
D009696:Nucleic Acids; D009243:NAD; D009536:Niacinamide; D009249:NADP; D004247:DNA; D010430:Pentosyltransferases; D009713:Nucleotidyltransferases